RRP9 and hepatocellular carcinoma: RAN (HR = 2.00, 95% CI:1.40–2.84, p < 0.001), RBM19 (HR = 1.59, 95% CI:1.12–2.25, p = 0.009), RRP9 (HR = 1.63, 95% CI:1.15–2.31, p = 0.006), SMARCD1 (HR = 1.96, 95% CI:1.38–2.79, p < 0.001), UTP20 (HR = 1.50, 95% CI:1.06–2.12, p = 0.022) (Figure 7), while DDX54, MPHOSPH10, and UTP3 were not associated with prognosis in HCC (Figure S3A–C).